Navigation Links
LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
Date:9/13/2011

f clinical trials, and the potential therapeutic and commercial potential, of LX4211. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX4211 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Unless specifically indicated otherwise, results reported as trends were not statistically significant. Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
2. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
3. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
4. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
5. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... éducatives gratuites et d,une conférence majeure dédiée à ... ) , Les formations ... Prendre en charge l,hypertension en ligne ...
(Date:7/2/2015)... 3, 2015 Pharma Major ... de participación en ZAO "Biocom" en Rusia bajo ... incursión de Lupin en el mercado farmacéutico de ... ventas, colocándolo como uno de los 10 principales ... Durante más de una década, el mercado farmacéutico ...
(Date:7/2/2015)... N.C. , July 2, 2015  New product ... of its leading role in educating thought leaders about ... that can heavily influence how well a new therapy ... new study from research and consulting leader Best Practices, ... leaders need to focus on are early stage thought ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... post-surgery hormone therapy reduced risk of breast cancer return ... First Phase III data to substantiate anticancer effect of ... prevention of bone complications due to bone metastases, with ... Feb. 11 /PRNewswire/ -- A newly published ...
... test to help guide treatment decisionsANN ARBOR, Mich., Feb. ... Comprehensive Cancer Center have identified a panel of ... prostate cancer.The finding could lead to a simple test ... slow-growing and which require immediate, aggressive treatment.Results of the ...
Cached Medicine Technology:Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 2Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 3Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 4Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 5Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 6Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 7Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 2Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 3
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... , ... First Choice Emergency Room , the largest network of independent ... new Medical Director of its Frisco facility. , “We are pleased to announce that ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... store located in Mississippi. The premium frozen yogurt chain was listed as #22 on ... at 104 Railroad Avenue, New Albany, MS 38652, will have a grand opening event ...
(Date:7/2/2015)... WIsconsin (PRWEB) , ... July 02, 2015 , ... ... for the parking structure retrofit project at the University of Minnesota, they knew ... is that it would also be an award-winning choice: the total energy savings ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth of July outdoors ... is on the rise. July is UV Safety Month, and physicians at American Family ... of getting skin checks. Experts say most skin cancers can be found early with ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... Four other factors, including gender and weight, play role ... 16 (HealthDay News) -- When it comes to the ... traditionally focused on is gestational age, but a new ... several factors that physicians and parents should consider when ...
... 17 A few years back, the,standard business card had ... side of plain vanilla paper stock, sometimes with,two-color printing to ... on both,sides of a BC in four-color process with a ... for 500 cards. This is a fraction,of what it cost ...
... CRM Holdings,Ltd. ("the Company") (Nasdaq: CRMH ) ... wholly-owned subsidiary of the Company, has,received notice from ... following an initial investigation, the WCB has determined ... CRM,s third party,administrator,s license to provide third party ...
... 16 Spencer Wyatt, an 8-year-old boy,living with epilepsy, ... Canine Assistants and UCB, Inc., the exclusive sponsor of ... in frequency and severity-allowing him to play sports, take,music ... that he may have,a seizure when his parents are ...
... Champions on Capitol Hill to Ask U.S. to,Meet Obligations ... The White Ribbon,Alliance for Safe Motherhood today took its ... Capitol Hill. Citing recent reports that the UN,Millennium Development ... is,unlikely to be met in Asia until 2076 and ...
... Restaurants Required to Provide Calorie Information, ALEXANDRIA, ... applauds today,s federal court ruling upholding,a New York ... the,calorie content of foods on their menus and ... challenge to the regulation filed by the New ...
Cached Medicine News:Health News:Gestational Age Not Sole Predictor of Preemie Survival 2Health News:Gestational Age Not Sole Predictor of Preemie Survival 3Health News:Your Business Card is a Powerful Marketing Tool 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 3Health News:Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 2Health News:White Ribbon Alliance Calls for Investments to Save Women's Lives Lost in Pregnancy and Childbirth 2Health News:Statement of the American Diabetes Association Supporting Federal Court's Ruling on New York City Proposal 2
TD silicone foam compression pad. Use with plates sealed with TDX or OptiTape....
The MicroAmp Centrifuge Adapter accomodates a single MicroAmp Reaction Tube with Cap and fits a standard microcentrifuge rotor. The adapter can be used up to 15,000 x g and should be used in pairs to...
PCR Workstation brings together UV irradiation and antimicrobial stainless steel to create a dual-attack environment against PCR contamination. PCR Workstation now available with a UV/Air Circulator ...
... tube racks. Its camera-based vision system captures and ... rack, making it ideal for use in automated ... a rack to be read automatically and can ... safety switch prevents a rack from being read ...
Medicine Products: